Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases

Main Article Content

Luigi Rossi (1), Angelo Zullo (2), Federica Zoratto (3), Anselmo Papa (4), Martina Strudel (5), Maria Colonna (6), Silverio Tomao (7*)

1 Department of Medico-Surgical Sciences and Biotechnologies, Oncology Unit, S.M. Goretti Hospital, Latina – “Sapienza” University of Rome, Italy.
2 Gastroenterology and Digestive Endoscopy; Nuovo Regina Margherita Hospital, Rome, Italy.
3 Department of Medico-Surgical Sciences and Biotechnologies, Oncology Unit, S.M. Goretti Hospital, Latina – “Sapienza” University of Rome, Italy.
4 Department of Medico-Surgical Sciences and Biotechnologies, Oncology Unit, S.M. Goretti Hospital, Latina – “Sapienza” University of Rome, Italy.
5 Department of Medico-Surgical Sciences and Biotechnologies, Oncology Unit, S.M. Goretti Hospital, Latina – “Sapienza” University of Rome, Italy.
6 , Italy.
7 Department of Medico-Surgical Sciences and Biotechnologies, Oncology Unit, S.M. Goretti Hospital, Latina – “Sapienza” University of Rome, Italy.
(*) Corresponding Author:
Silverio Tomao
silverio.tomao@uniroma1.it

Abstract

Although surgery is the most effective treatment for liver metastases in colorectal cancer patients, only 15-20% of these patients are suitable for a radical surgical approach, and metastases recurrence may occur at follow up. In the last decade, the use of pre-operative chemotherapy in combination with new biological drugs has been introduced. We reviewed data of neo-adjuvant chemotherapy strategies aimed at increasing the resection rate of liver metastases in colorectal cancer patients who were initially considered unresectable.

Downloads month by month

Downloads

Download data is not yet available.

Article Details

How to Cite
Rossi, L., Zullo, A., Zoratto, F., Papa, A., Strudel, M., Colonna, M., & Tomao, S. (2012). Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases. Oncology Reviews, 6(1), e6. https://doi.org/10.4081/oncol.2012.e6